Literature DB >> 35558152

Psychometric properties of the Polish version of two screening tests for gambling disorders: the Problem Gambling Severity Index and Lie/Bet Questionnaire.

Łukasz Wieczorek1, Daria Biechowska1, Katarzyna Dąbrowska1, Janusz Sierosławski1.   

Abstract

To date, no screening tests for gambling disorders have been adapted and validated in Central and Eastern Europe. The aim of this study is to adapt the Problem Gambling Severity Index (PGSI) and Lie/Bet questionnaire (Lie/Bet) and assess their psychometric properties once translated for use with the Polish population. A mixed sample (N = 300) was drawn from venues, social media, snowballing and treatment centers. PGSI had a higher coefficient of predictive power than Lie/Bet. However, differences between validated tests are not significant. Validation of screening tests of gambling disorders showed the necessity for verification of the scale of interpretation of results when conducting tests in Poland, changing cutoff values. The PGSI and Lie/Bet tests are short and easy to apply, they can be implemented in various types of institutions: for screening patients in primary health care facilities and for identifying comorbid gambling disorders in alcohol- and drug-dependence treatment facilities, and in social welfare centers.
© 2020 The Australian and New Zealand Association of Psychiatry, Psychology and Law.

Entities:  

Keywords:  Europe; Lie/Bet; Problem Gambling Severity Index; gambling; problem gambling; psychometric properties; screening tests

Year:  2021        PMID: 35558152      PMCID: PMC9090339          DOI: 10.1080/13218719.2020.1821824

Source DB:  PubMed          Journal:  Psychiatr Psychol Law        ISSN: 1321-8719


  14 in total

Review 1.  Guidelines for the process of cross-cultural adaptation of self-report measures.

Authors:  D E Beaton; C Bombardier; F Guillemin; M B Ferraz
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

2.  Problem gamblers: do GPs want to intervene?

Authors:  S Sullivan; B Arroll; G Coster; M Abbott; P Adams
Journal:  N Z Med J       Date:  2000-06-09

Review 3.  Gambling: an addictive behavior with health and primary care implications.

Authors:  Marc N Potenza; David A Fiellin; George R Heninger; Bruce J Rounsaville; Carolyn M Mazure
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

Review 4.  Assessing and treating problem gambling: empirical status and promising trends.

Authors:  Tony Toneatto; Goldie Millar
Journal:  Can J Psychiatry       Date:  2004-08       Impact factor: 4.356

5.  Motivators for change and barriers to help-seeking in Australian problem gamblers.

Authors:  Lyn Evans; Paul H Delfabbro
Journal:  J Gambl Stud       Date:  2005

6.  [Validation of ORTO-15 Questionnaire in the group of urban youth aged 15-21].

Authors:  Martyna Stochel; Małgorzata Janas-Kozik; Jan Zejda; Joanna Hyrnik; Ireneusz Jelonek; Andrzej Siwiec
Journal:  Psychiatr Pol       Date:  2015 Jan-Feb       Impact factor: 1.657

7.  Development and validation of the Japanese version of the problem gambling severity index.

Authors:  Ryuhei So; Sachio Matsushita; Sanae Kishimoto; Toshi A Furukawa
Journal:  Addict Behav       Date:  2019-05-13       Impact factor: 3.913

8.  Validation of the Polish Version of the Washington 4-Digit Diagnostic Code for the Assessment of Fetal Alcohol Spectrum Disorders.

Authors:  Małgorzata Klecka; Małgorzata Janas-Kozik; Ireneusz Jelonek; Andrzej Siwiec; Janusz Rybakowski
Journal:  Psychiatr Pol       Date:  2016-07-18       Impact factor: 1.657

9.  An assessment of the psychometric properties of Italian version of CPGI.

Authors:  Emanuela Colasante; Mercedes Gori; Luca Bastiani; Valeria Siciliano; Paolo Giordani; Mario Grassi; Sabrina Molinaro
Journal:  J Gambl Stud       Date:  2013-12

10.  Validation of the lie/bet screen for pathological gambling on two normal population data sets.

Authors:  K Gunnar Götestam; Agneta Johansson; Hanne Gro Wenzel; Inge-Ernald Simonsen
Journal:  Psychol Rep       Date:  2004-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.